↓ Skip to main content

Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma

Overview of attention for article published in Molecular Cancer Therapeutics, April 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs
1 blog
patent
1 patent
peer_reviews
1 peer review site

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma
Published in
Molecular Cancer Therapeutics, April 2006
DOI 10.1158/1535-7163.mct-05-0523
Pubmed ID
Authors

Laura Rosanò, Francesca Spinella, Valeriana Di Castro, Shoukat Dedhar, Maria Rita Nicotra, Pier Giorgio Natali, Anna Bagnato

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
United States 1 4%
Unknown 26 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 39%
Student > Ph. D. Student 4 14%
Student > Master 3 11%
Student > Doctoral Student 2 7%
Student > Bachelor 1 4%
Other 5 18%
Unknown 2 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 32%
Biochemistry, Genetics and Molecular Biology 8 29%
Medicine and Dentistry 6 21%
Chemistry 2 7%
Engineering 1 4%
Other 0 0%
Unknown 2 7%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2021.
All research outputs
#3,247,457
of 22,743,667 outputs
Outputs from Molecular Cancer Therapeutics
#496
of 3,861 outputs
Outputs of similar age
#6,998
of 66,128 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#6
of 57 outputs
Altmetric has tracked 22,743,667 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,861 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,128 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.